Clear Genetics is developing innovative, patient-centric software to thoughtfully integrate genetics into routine patient care. Our HIPAA-compliant platform offers an automated and comprehensive solution to deliver genetic services at scale. Clear Genetics serves leading health systems, clinics and commercial labs across the nation.
Prior to starting Clear Genetics (acquired by NVTA), Moran held several roles focused on increasing access and education to genetic testing in Israel. She was also at Medtronic, where she did business development and led business strategy. Moran did software engineering in Israel's military (Mammram), studied Biomedical engineering, and has an MBA from Wharton with a major in healthcare management.